A61K 38/2214
Motilins
Official title: {Motilins}
A61K38/2214 (Motilins) appears on 12 US grants and 17 published applications in this corpus.
Search patents in A61K- Granted patents
- 12
- Published applications
- 17
- Assignees
- 12
- Inventors
- 46
- Latest grant
- 7 Aug 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 1 | 4 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Intermediates for macrocyclic compounds7 Aug 2018US 10,040,751 B2Ocera Therapeutics, Inc.
- Postprandial gastrokinetic agent20 Jun 2017US 9,682,126 B2Saitama University
- Intermediates for macrocyclic compounds10 Nov 2015US 9,181,298 B2Ocera Therapeutics, Inc.
- Composition for nasal administration and method for preparing same12 Aug 2014US 8,802,622 B2Daiichi Sankyo Company, Limited
- Processes for intermediates for macrocyclic compounds30 Jul 2013US 8,497,242 B2Tranzyme Pharma Inc.
- Postprandial gastrokinetic agent22 Nov 2018US 2018/0333466 A1Saitama University
- Postprandial gastrokinetic agent31 Aug 2017US 2017/0246257 A1Saitama University
- Intermediates for macrocyclic compounds4 Aug 2016US 2016/0221927 A1Ocera Therapeutics, Inc.
- Postprandial gastrokinetic agent25 Feb 2016US 2016/0051630 A1Saitama University
- Use of obestatin for muscle regeneration2 Apr 2015US 2015/0094264 A1Servizo Galego De SAúDe
Most cited
By later US patents
- Macrocyclic antagonists of the motilin receptor36US 7,521,420 B2Tranzyme Pharma Inc. · 2009
- Pharmaceutical composition containing biologically active peptide or protein13US 5,733,877 ASanwa Kagaku Kenkyusho Co., Ltd. · 1998
- Processes for intermediates for macrocyclic compounds13US 8,129,561 B2Tranzyme Pharma Inc. · 2012
- Use of orally absorbable motilin preparations to enhance motility of digestive tract9US 5,468,728 ASanwa Kagaku Kenkyusho Co., Ltd. · 1995
- Methods of treating West Nile virus infection7US 6,946,125 B2The New York Hospital Medical Center of Queens · 2005